Oral Contraceptive Use Increases Risk of Inflammatory and Coagulatory Disorders in Women With Polycystic Ovarian Syndrome: An Observational Study

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-46644-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Association of Vascular and Inflammatory Markers With Metabolic Disorders in Women With Polycystic Ovary Syndrome

Vojnosanitetski Pregled
MedicinePharmacology
2019English

Timing of Births and Oral Contraceptive Use Influences Ovarian Cancer Risk

International Journal of Cancer
Cancer ResearchOncology
2017English

An Observational Study of Yasmin® in the Management of Women With Polycystic Ovary Syndrome

Journal of Family Planning and Reproductive Health Care
2004English

The Effect of Liraglutide on Weight Loss in Women With Polycystic Ovary Syndrome: An Observational Study

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Oral Contraceptive Use and the Risk of Cardiac Events in Patients With Long QT Syndrome

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2014English

Evaluation of Prolactin and Insulin Resistance in Women With Polycystic Ovarian Syndrome

International Journal of Medical Research and Review
2019English

Oral Contraceptive Use and Survival in Women With Invasive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Micronuclei Frequencies in Lymphocytes and Cervical Cells of Women With Polycystic Ovarian Syndrome

Turk Jinekoloji ve Obstetrik Dernegi Dergisi
GynecologyObstetrics
2017English

Oral Contraceptive Use and Ovarian Cancer Risk Among Carriers of BRCA1 or BRCA2 Mutations

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy